Although lysosomal storage disease is a rare disorder, it affects a large number of people. According to a December 2017 study published in Molecular Genetics and Metabolism Reports, the incidence of lysosomal storage disease ranges from one in 4000 to one in 13,000 live births. Lysosomal storage disease is characterised by 60 genetic abnormalities associated with poor enzyme function. As an orphan disease condition, regulatory agencies provide the benefit of rapid approval and ease in the approval process. Enzyme Replacement Therapy Market, in turn, is expected to expand the overall enzyme replacement therapy market with the introduction of new therapies by various key players.
Read More @ https://cmiinfonest.blogspot.com/2022/11/enzyme-replacement-therapy-market.html
Facebook Conversations